ea0025cm1.4 | The management of difficult Graves’ disease | SFEBES2011
Dayan Colin
While the aetiology of Graves disease is now well-established, treatment for Graves disease has largely remained unchanged for 50 years. However, relapse rates following antithyroid drug treatment remain high, destructive therapy to the thyroid is not without its short and longer-term risks and there have been limited studies of the benefits of different treatments in terms of long-term outcomes such as cardiovascular disease. There therefore remains much room for ...